![Boston Scientific Corporation Website](https://cdn.finchat.io/317627.png)
Boston Scientific Corporation
NYSE-BSX
Company Overview
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Name
Boston Scientific Corporation
CEO
Mr. Michael F. Mahoney
Website
www.bostonscientific.com
Sector
Health Care Equipment and Supplies
Year Founded
1979
Profile
Market Cap
$119.83B
EV
$128.09B
Shares Out
1,472.63M
Revenue
$15.23B
Employees
48,000
Margins
Gross
68.69%
EBITDA
25.92%
Operating
17.86%
Pre-Tax
14.06%
Net
12%
FCF
12.09%
Returns (5Yr Avg)
ROA
5.46%
ROTA
27.23%
ROE
11.65%
ROCE
6.99%
ROIC
-1.37%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$87.26
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$2,913M
Net Debt
$8,023M
Debt/Equity
0.53
EBIT/Interest
9.86
Growth (CAGR)
Rev 3Yr
10.8%
Rev 5Yr
8.61%
Rev 10Yr
7.86%
Dil EPS 3Yr
49.24%
Dil EPS 5Yr
4.39%
Dil EPS 10Yr
21.12%
Rev Fwd 2Yr
12.51%
EBITDA Fwd 2Yr
15.2%
EPS Fwd 2Yr
15.32%
EPS LT Growth Est
12.23%
Dividends
Yield
—
Payout
—
DPS
—
DPS Growth 3Yr
—
DPS Growth 5Yr
—
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
—